199 related articles for article (PubMed ID: 36038670)
1. DEGRO practical guideline for central nervous system radiation necrosis part 2: treatment.
Bernhardt D; König L; Grosu AL; Rieken S; Krieg SM; Wick W; Wiestler B; Schmidt-Graf F; Sahm F; Gempt J; Meyer B; Krause BJ; Petersen C; Fietkau R; Thomas M; Giordano F; Wittig-Sauerwein A; Debus J; Tabatabai G; Hau P; Steinbach J; Combs SE;
Strahlenther Onkol; 2022 Nov; 198(11):971-980. PubMed ID: 36038670
[TBL] [Abstract][Full Text] [Related]
2. DEGRO practical guideline for central nervous system radiation necrosis part 1: classification and a multistep approach for diagnosis.
Bernhardt D; König L; Grosu A; Wiestler B; Rieken S; Wick W; Gempt J; Krieg SM; Schmidt-Graf F; Sahm F; Meyer B; Krause BJ; Petersen C; Fietkau R; Thomas M; Giordano F; Wittig-Sauerwein A; Debus J; Tabatabai G; Hau P; Steinbach J; Combs SE;
Strahlenther Onkol; 2022 Oct; 198(10):873-883. PubMed ID: 36038669
[TBL] [Abstract][Full Text] [Related]
3. Single low-dose targeted bevacizumab infusion in adult patients with steroid-refractory radiation necrosis of the brain: a phase II open-label prospective clinical trial.
Dashti SR; Kadner RJ; Folley BS; Sheehan JP; Han DY; Kryscio RJ; Carter MB; Shields LBE; Plato BM; La Rocca RV; Spalding AC; Yao TL; Fraser JF
J Neurosurg; 2022 Dec; 137(6):1676-1686. PubMed ID: 35426830
[TBL] [Abstract][Full Text] [Related]
4. Targeted intraarterial anti-VEGF therapy for medically refractory radiation necrosis in the brain.
Dashti SR; Spalding A; Kadner RJ; Yao T; Kumar A; Sun DA; LaRocca R
J Neurosurg Pediatr; 2015 Jan; 15(1):20-5. PubMed ID: 25360851
[TBL] [Abstract][Full Text] [Related]
5. A Systematic Review Informing the Management of Symptomatic Brain Radiation Necrosis After Stereotactic Radiosurgery and International Stereotactic Radiosurgery Society Recommendations.
Vellayappan B; Lim-Fat MJ; Kotecha R; De Salles A; Fariselli L; Levivier M; Ma L; Paddick I; Pollock BE; Regis J; Sheehan JP; Suh JH; Yomo S; Sahgal A
Int J Radiat Oncol Biol Phys; 2024 Jan; 118(1):14-28. PubMed ID: 37482137
[TBL] [Abstract][Full Text] [Related]
6. Results of a questionnaire regarding practice patterns for the diagnosis and treatment of intracranial radiation necrosis after SRS.
Stockham AL; Ahluwalia M; Reddy CA; Suh JH; Kumar A; Vogelbaum MA; Barnett GH; Murphy ES; Chao ST
J Neurooncol; 2013 Dec; 115(3):469-75. PubMed ID: 24045970
[TBL] [Abstract][Full Text] [Related]
7. Bevacizumab as a treatment for radiation necrosis following stereotactic radiosurgery for brain metastases: clinical and radiation dosimetric impacts.
Li J; He J; Cai L; Lai M; Hu Q; Ren C; Wen L; Wang J; Zhou J; Zhou Z; Li S; Ye M; Shan C; Chen L; Zhou C
Ann Palliat Med; 2021 Feb; 10(2):2018-2026. PubMed ID: 33549015
[TBL] [Abstract][Full Text] [Related]
8. Bevacizumab as a treatment for radiation necrosis of brain metastases post stereotactic radiosurgery.
Boothe D; Young R; Yamada Y; Prager A; Chan T; Beal K
Neuro Oncol; 2013 Sep; 15(9):1257-63. PubMed ID: 23814264
[TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of bevacizumab and LITT for treating radiation necrosis in previously radiated CNS neoplasms: a systematic review and meta-analysis.
Gecici NN; Gurses ME; Kaye B; Jimenez NLF; Berke C; Gökalp E; Lu VM; Ivan ME; Komotar RJ; Shah AH
J Neurooncol; 2024 May; 168(1):1-11. PubMed ID: 38619777
[TBL] [Abstract][Full Text] [Related]
10. Post-stereotactic radiosurgery brain metastases: a review.
Fabiano AJ; Qiu J
J Neurosurg Sci; 2015 Jun; 59(2):157-67. PubMed ID: 25600555
[TBL] [Abstract][Full Text] [Related]
11. Bevacizumab as an effective treatment for radiation necrosis after radiotherapy for melanoma brain metastases.
Glitza IC; Guha-Thakurta N; D'Souza NM; Amaria RN; McGovern SL; Rao G; Li J
Melanoma Res; 2017 Dec; 27(6):580-584. PubMed ID: 28817446
[TBL] [Abstract][Full Text] [Related]
12. Expanding the Spectrum of Radiation Necrosis After Stereotactic Radiosurgery (SRS) for Intracranial Metastases From Lung Cancer: A Retrospective Review.
Sharma A; Mountjoy LJ; Butterfield RJ; Zhang N; Ross HJ; Schild SE; Sio TT; Daniels TB; Paripati HR; Mrugala MM; Vora SA; Patel NP; Zimmerman RS; Ashman JB; Porter AB
Am J Clin Oncol; 2020 Feb; 43(2):128-132. PubMed ID: 31764021
[TBL] [Abstract][Full Text] [Related]
13. DEGRO practical guideline for partial-breast irradiation.
Strnad V; Krug D; Sedlmayer F; Piroth MD; Budach W; Baumann R; Feyer P; Duma MN; Haase W; Harms W; Hehr T; Fietkau R; Dunst J; Sauer R;
Strahlenther Onkol; 2020 Sep; 196(9):749-763. PubMed ID: 32350554
[TBL] [Abstract][Full Text] [Related]
14. Resolution of radiation necrosis with bevacizumab following radiation therapy for primary CNS lymphoma.
Vaios EJ; Batich KA; Buckley AF; Dunn-Pirio A; Patel MP; Kirkpatrick JP; Goudar R; Peters KB
Oncotarget; 2022; 13():576-582. PubMed ID: 35359747
[TBL] [Abstract][Full Text] [Related]
15. Bevacizumab for radiation necrosis following radiotherapy of brain metastatic disease: a systematic review & meta-analysis.
Khan M; Zhao Z; Arooj S; Liao G
BMC Cancer; 2021 Feb; 21(1):167. PubMed ID: 33593308
[TBL] [Abstract][Full Text] [Related]
16. Radiation Necrosis from Stereotactic Radiosurgery-How Do We Mitigate?
Vellayappan BA; McGranahan T; Graber J; Taylor L; Venur V; Ellenbogen R; Sloan AE; Redmond KJ; Foote M; Chao ST; Suh JH; Chang EL; Sahgal A; Lo SS
Curr Treat Options Oncol; 2021 Jun; 22(7):57. PubMed ID: 34097171
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic radiosurgery and radiotherapy for resected brain metastases: current pattern of care in the Radiosurgery and Stereotactic Radiotherapy Working Group of the German Association for Radiation Oncology (DEGRO).
Rogers S; Baumert B; Blanck O; Böhmer D; Boström J; Engenhart-Cabillic R; Ermis E; Exner S; Guckenberger M; Habermehl D; Hemmatazad H; Henke G; Lohaus F; Lux S; Mai S; Minasch D; Rezazadeh A; Steffal C; Temming S; Wittig A; Zweifel C; Riesterer O; Combs SE
Strahlenther Onkol; 2022 Oct; 198(10):919-925. PubMed ID: 36006436
[TBL] [Abstract][Full Text] [Related]
18. Stereotactic radiosurgery for treatment of brain metastases. A report of the DEGRO Working Group on Stereotactic Radiotherapy.
Kocher M; Wittig A; Piroth MD; Treuer H; Seegenschmiedt H; Ruge M; Grosu AL; Guckenberger M
Strahlenther Onkol; 2014 Jun; 190(6):521-32. PubMed ID: 24715242
[TBL] [Abstract][Full Text] [Related]
19. Quality requirements for MRI simulation in cranial stereotactic radiotherapy: a guideline from the German Taskforce "Imaging in Stereotactic Radiotherapy".
Putz F; Bock M; Schmitt D; Bert C; Blanck O; Ruge MI; Hattingen E; Karger CP; Fietkau R; Grigo J; Schmidt MA; Bäuerle T; Wittig A
Strahlenther Onkol; 2024 Jan; 200(1):1-18. PubMed ID: 38163834
[TBL] [Abstract][Full Text] [Related]
20. Bevacizumab for stereotactic radiosurgery-induced radiation necrosis in patients with non-small cell lung cancer treated with immune check-point inhibitors.
Moore A; Yust-Katz S; Icht O; Eliyahou R; Gordon N; Cohen AY; Goldstein IM; Peled N; Seigal T; Amiel A; Dudnik E
J Neurol Sci; 2021 Aug; 427():117556. PubMed ID: 34186494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
